Finasteride and male breast cancer: Does the MHRA report show a link?
oleh: Niraj K Shenoy, Sangolli M Prabhakar
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer Medknow Publications 2010-01-01 |
Deskripsi
Finasteride is an important drug for the management of androgenetic alopecia. However, there are concerns about the possible side effects of the drug such as impotence. Recently stray reports have appeared about the occurrence of male breast carcinoma in patients who received the drug. These have been looked in to by Medicines and Health care products Regulatory Agency (MHRA). This article summarizes the MHRA report.